+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of erectile dysfunction in men screened for prostate cancer



Prevalence of erectile dysfunction in men screened for prostate cancer



Urology 74(1): 89-93



The Sexual Health Inventory for Men (SHIM) is a widely used scale for the screening and diagnosis of erectile dysfunction (ED). Our objective was to incorporate the SHIM into our prostate cancer screening program to estimate the prevalence of ED among men screened for prostate cancer. During September 2006, men younger than 75 years of age living in the Washington, DC area were invited to participate in the George Washington University Prostate Cancer Screening Program. The SHIM questionnaire was administered to all participants. Information regarding primary care physician use, phosphodiesterase-5 inhibitor use, serum prostate-specific antigen levels, and digital rectal examination findings was also obtained. Those who registered SHIM scores of 17 or less or who were taking a phosphodiesterase-5 inhibitor were considered to have ED. Overall, 333 men attended the program. Of the 328 men, 123 (37.5%) met our definition of ED; 30 (9%) were using a phosphodiesterase-5 inhibitor and 93 (28%) had an SHIM score of 17 or less. Univariate analysis suggested a significant difference in the prevalence of ED between African-American men and non-African-American men, with 25% and 41%, respectively, found to have a SHIM score of 17 or less (P < .01); however, this difference was not significant once we controlled for age (P > .05). Among our participants, 33% lacked a primary care physician. Of these, 22% had a SHIM score of 17 or less. The results of our study have shown that ED increases in a nonlinear fashion with age, consistent with the findings of previous reports. Of greater concern, however, given the strong association between ED and cardiovascular disease, was the number of those with ED who lacked a primary care physician.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157617

Download citation: RISBibTeXText

PMID: 19428072

DOI: 10.1016/j.urology.2008.03.036


Related references

The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer. Bju International 104(8): 1130-1133, 2009

Prevalence of undiagnosed prostate cancer in men with erectile dysfunction. BJU International 89(3): 261-263, February, 2002

Baseline prevalence of erectile dysfunction in a prostate cancer screening population. Journal of Sexual Medicine 5(2): 428-435, 2007

Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer. Journal of Sexual Medicine 12(5): 1267-1274, 2015

Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base. Journal of Urology 169(4): 1458-1461, 2003

The prevalence and outcome of therapy for erectile dysfunction 4 to 8 years following brachytherapy, external radiation and radical prostatectomy for localized prostate cancer. Journal of Urology 171(4 Supplement): 239-240, April, 2004

Prevalence of erectile dysfunction as defined by the International Index of Erectile Function (IIEF) and self-reported erectile dysfunction in a sample of Brazilian men who consider themselves healthy. Journal of Sex & Marital Therapy 36(1): 87-100, 2010

Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years. Urology 69(4): 743-747, 2007

Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy. Medical Journal of Australia 200(10): 582-585, 2014

Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. Bju International 111(1): 38-43, 2013

Re: Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. Journal of Urology 188(6): 2317-2318, 2012

Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61(1): 201-206, 2003

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. Journal of Urology 182(6): 2664-2669, 2009

Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database. Journal of Sexual Medicine 9(4): 1174-1181, 2012

Prevalence of erectile dysfunction in Thailand. Thai Erectile Dysfunction Epidemiological Study Group. International Journal of Andrology 23 Suppl 2: 77-80, 2000